177 reports of this reaction
1.7% of all ISTRADEFYLLINE reports
#15 most reported adverse reaction
PARKINSON^S DISEASE is the #15 most commonly reported adverse reaction for ISTRADEFYLLINE, manufactured by Kyowa Kirin, Inc.. There are 177 FDA adverse event reports linking ISTRADEFYLLINE to PARKINSON^S DISEASE. This represents approximately 1.7% of all 10,328 adverse event reports for this drug.
Patients taking ISTRADEFYLLINE who experience parkinson^s disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PARKINSON^S DISEASE is a less commonly reported adverse event for ISTRADEFYLLINE, but still significant enough to appear in the safety profile.
In addition to parkinson^s disease, the following adverse reactions have been reported for ISTRADEFYLLINE:
The following drugs have also been linked to parkinson^s disease in FDA adverse event reports:
PARKINSON^S DISEASE has been reported as an adverse event in 177 FDA reports for ISTRADEFYLLINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PARKINSON^S DISEASE accounts for approximately 1.7% of all adverse event reports for ISTRADEFYLLINE, making it a notable side effect.
If you experience parkinson^s disease while taking ISTRADEFYLLINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.